Over the last 7 days, the Clinical Research and Equipment industry has dropped 14%, driven by SCHOTT Pharma KGaA declining 0.6%. Overall the industry is down 21% in 12 months. Looking forward, earnings are forecast to grow by 28% annually.
Has the German Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 24 Apr 2024 | €30.0b | €7.0b | €329.0m | 37.2x | 91.1x | 4.3x |
Fri, 22 Mar 2024 | €35.0b | €7.1b | €384.5m | 39.1x | 91x | 4.9x |
Sun, 18 Feb 2024 | €32.2b | €7.1b | €369.5m | 36.9x | 87.2x | 4.5x |
Tue, 16 Jan 2024 | €30.2b | €7.3b | €507.1m | 35.5x | 59.6x | 4.2x |
Thu, 14 Dec 2023 | €30.4b | €7.3b | €507.1m | 32.5x | 59.9x | 4.2x |
Sat, 11 Nov 2023 | €26.1b | €7.3b | €507.1m | 30.2x | 51.5x | 3.6x |
Mon, 09 Oct 2023 | €26.1b | €6.6b | €498.8m | 38.1x | 52.4x | 3.9x |
Wed, 06 Sep 2023 | €30.5b | €6.6b | €498.1m | 44.7x | 61.2x | 4.6x |
Fri, 04 Aug 2023 | €30.6b | €6.6b | €425.8m | 42.6x | 72x | 4.7x |
Sun, 02 Jul 2023 | €26.9b | €6.7b | €487.3m | 37.5x | 55.2x | 4x |
Tue, 30 May 2023 | €27.1b | €6.7b | €487.3m | 37.8x | 55.6x | 4x |
Thu, 27 Apr 2023 | €27.7b | €6.7b | €483.0m | 38.2x | 57.3x | 4.2x |
Sat, 25 Mar 2023 | €30.1b | €6.7b | €594.3m | 34.8x | 50.6x | 4.5x |
Mon, 20 Feb 2023 | €32.2b | €6.5b | €447.4m | 40.3x | 71.9x | 5x |
Wed, 18 Jan 2023 | €31.3b | €6.5b | €447.4m | 38.3x | 70x | 4.8x |
Fri, 16 Dec 2022 | €27.8b | €6.5b | €447.4m | 33.6x | 62.2x | 4.3x |
Sun, 13 Nov 2022 | €31.5b | €6.5b | €447.4m | 38.3x | 70.4x | 4.9x |
Tue, 11 Oct 2022 | €28.0b | €6.2b | €573.0m | 52x | 48.9x | 4.5x |
Thu, 08 Sep 2022 | €5.5b | €2.3b | €84.0m | 1204.2x | 65x | 2.4x |
Sat, 06 Aug 2022 | €6.8b | €2.3b | €171.9m | 38.8x | 39.5x | 3x |
Mon, 04 Jul 2022 | €6.0b | €2.2b | €174.9m | 34.2x | 34.5x | 2.7x |
Wed, 01 Jun 2022 | €6.8b | €2.2b | €173.3m | 38.3x | 39x | 3x |
Fri, 29 Apr 2022 | €6.2b | €2.2b | €299.3m | 21.8x | 20.8x | 2.8x |
Sun, 27 Mar 2022 | €7.1b | €2.1b | €342.9m | 18.9x | 20.6x | 3.4x |
Tue, 22 Feb 2022 | €6.9b | €2.1b | €342.9m | 17.8x | 20.2x | 3.3x |
Thu, 20 Jan 2022 | €9.0b | €2.0b | €345.8m | 25.5x | 26x | 4.4x |
Sat, 18 Dec 2021 | €10.1b | €2.0b | €345.8m | 29.1x | 29.2x | 4.9x |
Mon, 15 Nov 2021 | €10.1b | €2.0b | €345.7m | 28.3x | 29.2x | 4.9x |
Wed, 13 Oct 2021 | €9.4b | €2.0b | €222.9m | 26.4x | 42x | 4.7x |
Fri, 10 Sep 2021 | €10.2b | €2.0b | €222.8m | 30.6x | 45.9x | 5.2x |
Sun, 08 Aug 2021 | €9.0b | €2.0b | €222.8m | 29.7x | 40.5x | 4.6x |
Sat, 01 May 2021 | €8.7b | €1.9b | €155.3m | 30x | 55.9x | 4.5x |
55.9x
How does German Clinical Research and Equipment compare with similar industries?
DE Market | 1.82% | |
Healthcare | 0.65% | |
Life Sciences | -7.51% | |
Clinical Research and Equipment | -7.51% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1SXP SCHOTT Pharma KGaA | €39.04 | 3.6% +€201.8m | n/a | PE37.2x | |
EVT Evotec | €14.18 | 7.3% +€172.0m | -12.8% | PS3.1x | |
GXI Gerresheimer | €102.00 | 2.1% +€70.8m | 6.1% | PE30.1x |